Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
3.870
+0.040 (1.04%)
At close: Nov 19, 2025, 4:00 PM EST
3.870
0.00 (0.00%)
After-hours: Nov 19, 2025, 4:10 PM EST
Zura Bio Stock Forecast
Stock Price Forecast
The 8 analysts that cover Zura Bio stock have a consensus rating of "Strong Buy" and an average price target of $11.38, which forecasts a 194.06% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $18.
Price Target: $11.38 (+194.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Zura Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
| Buy | 4 | 4 | 5 | 4 | 4 | 3 |
| Hold | 1 | 1 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +158.40% | Nov 14, 2025 |
| Clear Street | Clear Street | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +365.12% | Nov 13, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +158.40% | Sep 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -48.32% | Aug 19, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | +313.44% | Aug 15, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.74
from -0.60
EPS Next Year
-0.80
from -0.74
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.67 | -0.74 | |
| Avg | -0.74 | -0.80 | |
| Low | -0.76 | -0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.